货币 / JAZZ
JAZZ: Jazz Pharmaceuticals plc
116.12
USD
0.53
(0.45%)
今日JAZZ汇率已更改-0.45%。当日,交易品种以低点115.29和高点117.15进行交易。
关注Jazz Pharmaceuticals plc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
JAZZ新闻
- Zacks Sarepta Therapeutics (SRPT) to Report Q2 Results: Wall Street Expects Earnings Growth
- Zacks Earnings Preview: Jazz Pharmaceuticals (JAZZ) Q2 Earnings Expected to Decline
- Zacks Strength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength?
- Zacks ALKS Down Despite Positive Top-Line Data From Narcolepsy Study
- Seeking Alpha Polaris Global Equity Composite Q2 2025 Commentary
- Investor's Business Daily Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.
- Seeking Alpha XPH: Healthcare Dashboard For July (NYSEARCA:XPH)
- Investing Deutsche Bank initiates Jazz Pharmaceuticals stock with Buy rating
- Investor's Business Daily Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
- Investing Jazz Pharmaceuticals names Renee Gala as next CEO
- TipRanks 3 Must-Watch Stocks with a ‘Perfect 10’ Smart Score - TipRanks.com
- Investing Harmony Biosciences stock resumes coverage at Goldman Sachs with Neutral rating
- Seeking Alpha Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor (NASDAQ:JAZZ)
- Investing PharmaMar FY 2024 slides: Revenue up 11%, net profit soars amid clinical advances
- Investing Zymeworks stock holds steady as H.C. Wainwright reiterates Neutral rating
- Benzinga Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On Lumryz - Avadel Pharmaceuticals (NASDAQ:AVDL)
- Investing European Commission approves Jazz Pharmaceuticals’ Ziihera for rare cancer
- Investing Avadel stock rises after appeals court upholds LUMRYZ approval
- Seeking Alpha STOK: Impressive Pipeline And Big Backers (NASDAQ:STOK)
- Seeking Alpha Amgen Stock: Imdelltra Data And Q1 Results Impress (NASDAQ:AMGN)
- Investing FDA grants priority review to Zepzelca combo for ES-SCLC
- Investing Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav ® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025
- Seeking Alpha ASCO 2025: Profiling The Biggest Presentations At The Biggest Cancer Meeting
- Seeking Alpha Harmony Biosciences: If It Ain't Broke (NASDAQ:HRMY)
日范围
115.29
117.15
年范围
95.49
148.06
- 前一天收盘价
- 116.60
- 开盘价
- 116.65
- 卖价
- 116.12
- 买价
- 116.42
- 最低价
- 115.29
- 最高价
- 117.15
- 交易量
- 1.206 K
- 日变化
- -0.45%
- 月变化
- 10.16%
- 6个月变化
- -5.06%
- 年变化
- 2.82%
31 七月, 星期四
11:30
USD
- 实际值
- 预测值
- 前值
- 47.999 K
11:30
USD
- 实际值
- 预测值
- -68.3%
- 前值
- -1.6%
12:30
USD
- 实际值
- 预测值
- 0.4%
- 前值
- 0.2%
12:30
USD
- 实际值
- 预测值
- 2.6%
- 前值
- 2.7%
12:30
USD
- 实际值
- 预测值
- 0.2%
- 前值
- 0.1%
12:30
USD
- 实际值
- 预测值
- 2.3%
- 前值
- 2.3%
12:30
USD
- 实际值
- 预测值
- 0.2%
- 前值
- -0.1%
12:30
USD
- 实际值
- 预测值
- 0.7%
- 前值
- -0.4%
12:30
USD
- 实际值
- 预测值
- 0.0%
- 前值
- -0.3%
12:30
USD
- 实际值
- 预测值
- 0.9%
- 前值
- 0.9%
12:30
USD
- 实际值
- 预测值
- 1.0%
- 前值
- 1.2%
12:30
USD
- 实际值
- 预测值
- 0.7%
- 前值
- 0.8%
12:30
USD
- 实际值
- 预测值
- 224 K
- 前值
- 217 K
12:30
USD
- 实际值
- 预测值
- 1.966 M
- 前值
- 1.955 M
12:30
USD
- 实际值
- 预测值
- 222.299 K
- 前值
- 224.500 K
13:45
USD
- 实际值
- 预测值
- 42.4
- 前值
- 40.4
14:00
USD
- 实际值
- 预测值
- 2.3%
- 前值
- 2.0%
14:30
USD
- 实际值
- 预测值
- 2 B
- 前值
- 23 B
15:30
USD
- 实际值
- 预测值
- 前值
- 4.245%
15:30
USD
- 实际值
- 预测值
- 前值
- 4.265%